NCT01596894View on ClinicalTrials.gov

Azithromycin Based Therapy for Induction of Remission in Active Pediatric Crohn's Disease

PHASE4CompletedINTERVENTIONAL
Enrollment

73

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Crohn's Disease
Interventions
DRUG

Azithromycin + Metronidazole

Azithromycin 7.5 mg/kg once daily (maximum 500mg) 5 consecutive days a week for the first 4 weeks and 3 consecutive days a week for the next 4 weeks +metronidazole 10mg/kg X2/day (maximum 1000mg) for 8 weeks.

DRUG

Metronidazole

Oral metronidazole 10mg/kg X2/day (maximum 1000mg) for 8 weeks.

Trial Locations (1)

58100

The E. Wolfson.Medical Center, Holon

All Listed Sponsors
lead

Prof. Arie Levine

OTHER_GOV

NCT01596894 - Azithromycin Based Therapy for Induction of Remission in Active Pediatric Crohn's Disease | Biotech Hunter | Biotech Hunter